Naproxennatrium Htp (Naproxen Sodium)

Naproxen Sodium, the active ingredient in Naproxennatrium Htp, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain, inflammation, fever and arthritis in adult patients. GNH USA supplies Naproxennatrium Htp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen Sodium is an NSAID that reduces pain and inflammation across several common conditions.

Pain: Provides analgesic relief for acute and chronic musculoskeletal pain. Inflammation: Decreases swelling associated with soft‑tissue injuries and inflammatory disorders. Fever: Lowers elevated body temperature in febrile states. Arthritis: Alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort such as dyspepsia or heartburn. - Nausea or mild vomiting. - Headache or dizziness. - Mild skin rash or itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or sudden loss of kidney function. - Severe hypersensitivity reactions, including anaphylaxis. - Elevated liver enzymes indicating hepatic stress. - Cardiovascular events such as myocardial infarction or stroke, particularly with long‑term use.

Before initiating therapy, consider the following safety measures. - Renal Function: Assess kidney function in patients with pre‑existing renal disease. - Gastrointestinal Risk: Use caution in individuals with a history of ulcers or GI bleeding. - Cardiovascular Health: Evaluate cardiovascular risk factors, especially in long‑term users. - Concomitant Medications: Review all current drugs for potential interactions. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Drug‑drug interactions can modify efficacy or increase toxicity.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): May markedly increase bleeding risk. - Selective COX‑2 inhibitors: Combined use can heighten cardiovascular and gastrointestinal adverse events.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: May reduce renal perfusion, requiring monitoring of kidney function. - Lithium: NSAIDs can raise lithium serum levels, necessitating dose adjustment. - Methotrexate: Concomitant use may increase methotrexate toxicity, especially at high doses.